IMDX vs MSFT: Which Stock is Better?
Side-by-side comparison of Insight Molecular Diagnostics Inc and Microsoft Corp in 2026
IMDX
Insight Molecular Diagnostics Inc
$3.00
MSFT
Microsoft Corp
$387.00
Key Metrics Comparison
| Metric | IMDX | MSFT | Winner |
|---|---|---|---|
| Market Cap | $101.97M | N/A | IMDX |
| P/E Ratio | N/A | 24.04 | MSFT |
| EPS (TTM) | $N/A | $15.99 | MSFT |
| Revenue Growth | -0.2% | 0.2% | MSFT |
| Gross Margin | 56.8% | 68.6% | MSFT |
Analyze IMDX
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMDX or MSFT a better investment?
Comparing IMDX and MSFT: Insight Molecular Diagnostics Inc has a market cap of $101.97M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMDX and MSFT?
IMDX (Insight Molecular Diagnostics Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMDX or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMDX or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.2% for IMDX.
Which company is more profitable: IMDX or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 56.8% for IMDX.
Which is the larger company: IMDX or MSFT?
Insight Molecular Diagnostics Inc (IMDX) is larger with a market cap of $101.97M compared to N/A for MSFT.
Should I buy IMDX or MSFT in 2026?
Both IMDX and MSFT have investment merit. IMDX trades at $3.00 while MSFT trades at $387.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMDX and MSFT stock?
Key differences: Market Cap ($101.97M vs N/A), P/E Ratio (N/A vs 24.0x), Revenue Growth (-0.2% vs 0.2%), Gross Margin (56.8% vs 68.6%).